Congenital cytomegalovirus infection: treatment, sequelae and follow-up

References

• Nassetta L, Kimberlin D, Whitley. Treatment of congenital cytomegalovirus infection: implications for future strategies. JAC Antiviral 2009;63:862–867.
   Google Scholar
• Barbi M, Binda S, Caroppo S, Calvario A, Germinario C, Bozzi A, Tanzi ML, Veronesi L, Mura I, Piana A, et al Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis J 2006;25:156–159.
   PubMed Web of Science ®Google Scholar
• Coll O, Benoist G, Ville Y, Weisman LE, Botet F, Anceschi MM, Greenough A, Gibbs RS, Carbonell-Estrany X. Guidelines on CMV congenital infection. J Perinat Med. 2009;37:433–445.
   PubMed Web of Science ®Google Scholar
• Schleiss MR. Congenital cytomegalovirus infection: update on management strategies. Curr treat opinions 2008;10:186–192.
   PubMedGoogle Scholar
• Nigro G, Adler SP, La Torre R, Best AM. Congenital Cytomegalovirus Collaborating Group. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med. 2005;353:1350–1362.
   PubMed Web of Science ®Google Scholar
• Michaels MG. Treatment of congenital cytomegalovirus: where are we now? Expert Rev Anti Infect Ther 2007;5:441–448.
   PubMed Web of Science ®Google Scholar
• Oliver SE, Cloud GA, Sánchez PJ, Demmler GJ, Dankner W, Shelton M, Jacobs RF, Vaudry W, Pass RF, Soong SJ, Whitley RJ, Kimberlin DW. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 2009;4:S22–S26.
   Google Scholar
• Galli L, Novelli A, Chiappini E Gervaso P, Cassetta MI, Fallani S, de Martino M. Valganciclovir for congenital CMV infection: a pilot study on plasma concentration in newborns and infants. Ped Infec Dis J 2007;26:451–453.
   PubMed Web of Science ®Google Scholar
• Kimberlin DW, Acosta EP, Sanchez PJ. Pharmacokinetic and Pharmacodynamic assessment of oral Valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. 2008; J Infect Dis 197:836–845.
   PubMed Web of Science ®Google Scholar
• Lombardi G, Garofoli F, Villani P, Tizzoni M, Angelini M, Cusato M, Bollani L, De Silvestri A, Regazzi M, Stronati M. Oral Valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection. Eur J Clin Microbiol Infect Dis 2009;28:1465–1470.
   PubMed Web of Science ®Google Scholar
• Amir J, Wolf DG, Levy I. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir. Eur J Pediatr 2010;169:1061–1067. [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Hilgendorff A, Daiminger A, Dangel V, Kreuder J, Geidel C, Reiss I, Enders G. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age. Klin Padiatr 2009;221:448–449.
   PubMedGoogle Scholar
• Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007;17:355–363.
   PubMed Web of Science ®Google Scholar
• Pass RF, Fowler RB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symtoms at birth and outcome. J Clin Virol 2006;35:216–220.
   PubMed Web of Science ®Google Scholar
• Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B Landini MP, Faldella G. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2002;117:e76–e83.
   Google Scholar
• Arav-Boger R, Battaglia CA, Lazzarotto T, Gabrielli L, Zong JC, Hayward GS,Diener-West M, Landini MP. Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. J Infect Dis 2006;1944:64–73.
   Google Scholar
• Fowler KB, Dahle AJ, Boppana SB, Pass RF. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr 1999;135:60–64.
   PubMed Web of Science ®Google Scholar
• Rivera LB, Boppana S, Fowler K, Britt WJ, Stagno S, Pass R. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection. Pediatr 2002;110:762–767.
   PubMed Web of Science ®Google Scholar
• Boppana S, Amos C, Britt W, Stagno S, Alford C, Pass R. Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection. Pediatr Infect Dis J 1994;13:1139–1142.
   PubMed Web of Science ®Google Scholar
• Ivarsson SA, Lernmark B, Svanberg L. Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age. Pediatrics 1997;99:800–803.
   PubMed Web of Science ®Google Scholar
• Boppana SB, Fowler KB, Vaid Y, Hedlund G, Stagno S, Britt WJ, Pass RF. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997;99:409–414.
   PubMed Web of Science ®Google Scholar
• Noyola DE., Demmler GJ., Nelson T, Griesser C, Williamson WD, Atkins JT, Rozelle J, Turcich M, Llorente AM, Sellers-Vinson S, et al Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Ped 2001;138:325–331.
   PubMed Web of Science ®Google Scholar
• de Vries LS, Verboon-Maciolek MA, Cowan FM, Groenendaal F. The role of cranial ultrasound and magnetic resonance imaging in the diagnosis of infections of the central nervous system. Early Hum Dev 2006;82:819–825.
   PubMed Web of Science ®Google Scholar